BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28546135)

  • 1. Neoadjuvant Hypofractionated Radiotherapy and Chemotherapy in High-Grade Extremity Soft Tissue Sarcomas: Phase 2 Clinical Trial Protocol.
    Spencer RM; Aguiar Junior S; Ferreira FO; Stevanato Filho PR; Kupper BE; Silva ML; Mello CA; Bezerra TS; Lopes A
    JMIR Res Protoc; 2017 May; 6(5):e97. PubMed ID: 28546135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant hypofractionated radiotherapy and chemotherapy for extremity soft tissue sarcomas: Safety, feasibility, and early oncologic outcomes of a phase 2 trial.
    Gobo Silva ML; Lopes de Mello CA; Aguiar Junior S; D'Almeida Costa F; Stevanato Filho PR; Santoro Bezerra T; Nakagawa SA; Nascimento AG; Werneck da Cunha I; Spencer Sobreira Batista RM; Nicolau Daher UR; Da Cruz Formiga MN; Germano JN; Catin Kupper BE; De Assis Pellizzon AC; Lopes A
    Radiother Oncol; 2021 Jun; 159():161-167. PubMed ID: 33798613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Preoperative Hypofractionated Radiotherapy With Doxorubicin-Ifosfamide Chemotherapy in Marginally Resectable Soft Tissue Sarcomas: Results of a Phase 2 Clinical Trial.
    Spałek MJ; Koseła-Paterczyk H; Borkowska A; Wągrodzki M; Szumera-Ciećkiewicz A; Czarnecka AM; Castaneda-Wysocka P; Kalinowska I; Poleszczuk J; Dąbrowska-Szewczyk E; Cieszanowski A; Rutkowski P
    Int J Radiat Oncol Biol Phys; 2021 Jul; 110(4):1053-1063. PubMed ID: 33600887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of a phase 2 study of neoadjuvant chemotherapy and radiotherapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514.
    Kraybill WG; Harris J; Spiro IJ; Ettinger DS; DeLaney TF; Blum RH; Lucas DR; Harmon DC; Letson GD; Eisenberg B
    Cancer; 2010 Oct; 116(19):4613-21. PubMed ID: 20572040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective phase II trial of preoperative hypofractionated proton therapy for extremity and truncal soft tissue sarcoma: the PRONTO study rationale and design.
    Gogineni E; Chen H; Hu C; Boudadi K; Engle J; Levine A; Deville C
    Radiat Oncol; 2024 May; 19(1):56. PubMed ID: 38745333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant Interdigitated Chemoradiotherapy Using Mesna, Doxorubicin, and Ifosfamide for Large, High-grade, Soft Tissue Sarcomas of the Extremity: Improved Efficacy and Reduced Toxicity.
    Chowdhary M; Sen N; Jeans EB; Miller L; Batus M; Gitelis S; Wang D; Abrams RA
    Am J Clin Oncol; 2019 Jan; 42(1):1-5. PubMed ID: 29782358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomas.
    Mullen JT; Kobayashi W; Wang JJ; Harmon DC; Choy E; Hornicek FJ; Rosenberg AE; Chen YL; Spiro IJ; DeLaney TF
    Cancer; 2012 Aug; 118(15):3758-65. PubMed ID: 22180344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Outcomes With Ifosfamide-based Hypofractionated Preoperative Chemoradiotherapy for Extremity Soft Tissue Sarcomas.
    Pennington JD; Eilber FC; Eilber FR; Singh AS; Reed JP; Chmielowski B; Eckardt JJ; Bukata SV; Bernthal NM; Federman N; Nelson SD; Dry SM; Wang PC; Luu M; Selch MT; Steinberg ML; Kalbasi A; Kamrava M
    Am J Clin Oncol; 2018 Dec; 41(12):1154-1161. PubMed ID: 29664796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG).
    Ferrari A; van Noesel MM; Brennan B; Zanetti I; Corradini N; Casanova M; Berlanga P; Merks JHM; Alaggio R; Schifflers S; Ramirez-Villar GL; Giraudo C; Burrieza GG; Safwat A; Bisogno G; De Salvo GL; Orbach D
    Lancet Child Adolesc Health; 2021 Aug; 5(8):546-558. PubMed ID: 34214481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant irradiation of extremity soft tissue sarcoma with ions (Extrem-ion): study protocol for a randomized phase II pilot trial.
    Brügemann D; Lehner B; Kieser M; Krisam J; Hommertgen A; Jaekel C; Harrabi SB; Herfarth K; Mechtesheimer G; Sedlaczek O; Egerer G; Geisbüsch A; Uhl M; Debus J; Seidensaal K
    BMC Cancer; 2022 May; 22(1):538. PubMed ID: 35550036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative hypofractionated radiotherapy for soft tissue sarcomas: a systematic review.
    Roohani S; Ehret F; Kobus M; Flörcken A; Märdian S; Striefler JK; Rau D; Öllinger R; Jarosch A; Budach V; Kaul D
    Radiat Oncol; 2022 Sep; 17(1):159. PubMed ID: 36104789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas.
    DeLaney TF; Spiro IJ; Suit HD; Gebhardt MC; Hornicek FJ; Mankin HJ; Rosenberg AL; Rosenthal DI; Miryousefi F; Ancukiewicz M; Harmon DC
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1117-27. PubMed ID: 12829150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor.
    Edmonson JH; Petersen IA; Shives TC; Mahoney MR; Rock MG; Haddock MG; Sim FH; Maples WJ; O'Connor MI; Gunderson LL; Foo ML; Pritchard DJ; Buckner JC; Stafford SL
    Cancer; 2002 Feb; 94(3):786-92. PubMed ID: 11857314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of Preoperative Chemotherapy With or Without Radiation Therapy in Localized Soft Tissue Sarcomas of Limbs and Superficial Trunk in the Italian Sarcoma Group/Grupo Español de Investigación en Sarcomas Randomized Clinical Trial: Three Versus Five Cycles of Full-Dose Epirubicin Plus Ifosfamide.
    Palassini E; Ferrari S; Verderio P; De Paoli A; Martin Broto J; Quagliuolo V; Comandone A; Sangalli C; Palmerini E; Lopez-Pousa A; De Sanctis R; Bottelli S; Libertini M; Picci P; Casali PG; Gronchi A
    J Clin Oncol; 2015 Nov; 33(31):3628-34. PubMed ID: 26351345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on Dosing and Fractionation for Neoadjuvant Radiotherapy for Localized Soft Tissue Sarcoma.
    Roohani S; Wiltink LM; Kaul D; Spałek MJ; Haas RL
    Curr Treat Options Oncol; 2024 Apr; 25(4):543-555. PubMed ID: 38478330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant image-guided helical intensity modulated radiotherapy of extremity sarcomas - a single center experience.
    Peeken JC; Knie C; Kessel KA; Habermehl D; Kampfer S; Dapper H; Devecka M; von Eisenhart-Rothe R; Specht K; Weichert W; Wörtler K; Knebel C; Wilkens JJ; Combs SE
    Radiat Oncol; 2019 Jan; 14(1):2. PubMed ID: 30626408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy plus radiation versus chemotherapy plus regional hyperthermia in high-grade soft tissue sarcomas: a retrospective comparison.
    Zschaeck S; Wust P; Melcher I; Nadobny J; Rau D; Striefler J; Pahl S; Flörcken A; Kunitz A; Ghadjar P
    Int J Hyperthermia; 2018; 35(1):1-9. PubMed ID: 30300018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant sequential chemoradiotherapy versus radiotherapy alone for treatment of high-risk extremity soft tissue sarcoma: a single-institution experience.
    Kılıç L; Ekenel M; Karabulut S; Ağaoğlu F; Darendeliler E
    Contemp Oncol (Pozn); 2017; 21(1):60-65. PubMed ID: 28435400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of Preoperative Radiotherapy for Sarcomas of the Extremities with Intensity-Modulation, Image-Guidance and Small Safety-margins (PREMISS).
    Röper B; Heinrich C; Kehl V; Rechl H; Specht K; Wörtler K; Töpfer A; Molls M; Kampfer S; von Eisenharth-Rothe R; Combs SE
    BMC Cancer; 2015 Nov; 15():904. PubMed ID: 26573139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant irradiation of retroperitoneal soft tissue sarcoma with ions (Retro-Ion): study protocol for a randomized phase II pilot trial.
    Seidensaal K; Kieser M; Hommertgen A; Jaekel C; Harrabi SB; Herfarth K; Mechtesheimer G; Lehner B; Schneider M; Nienhueser H; Fröhling S; Egerer G; Debus J; Uhl M
    Trials; 2021 Feb; 22(1):134. PubMed ID: 33579340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.